Herbal Monograph
Red Clover
Trifolium pratense L.
Fabaceae (Leguminosae)
Premier alterative and lymphatic herb with clinically supported phytoestrogenic isoflavones for menopausal relief...
Overview
Plant Description
Red clover is a short-lived herbaceous perennial (sometimes biennial) plant growing 20-80 cm (8-31 inches) tall from a stout, branching taproot with an extensive system of fibrous lateral roots bearing characteristic nitrogen-fixing root nodules (symbiotic with Rhizobium leguminosarum biovar trifolii). Stems are erect to ascending, branching, softly hairy, and somewhat hollow. The trifoliate leaves are the hallmark of the genus: each leaf consists of three broadly elliptical to obovate leaflets, 1.5-3.5 cm long, each typically bearing a distinctive pale, chevron-shaped or V-shaped marking (the 'watermark') on the upper surface. Leaflets have entire to finely toothed margins and are softly pubescent. Stipules are large, membranous, and adnate to the petiole, with triangular, bristle-tipped free portions. The inflorescence is a dense, globose to ovoid head, 2-3 cm in diameter, composed of 50-200 sessile individual papilionaceous (pea-type) florets. Florets are typically rose-pink to magenta-purple (rarely white), 12-18 mm long, with a tubular calyx and the characteristic Fabaceae flower structure of banner (standard), wings, and keel petals. Two leaves subtend each flower head, giving a distinctive 'collared' appearance. Flowering occurs from late spring through early autumn (May-September in the Northern Hemisphere). Fruit is a small, one-seeded (occasionally two-seeded), indehiscent pod enclosed within the persistent calyx. Seeds are tiny (1-2 mm), kidney-shaped, and yellow to brownish. The entire plant has a mild, sweet, hay-like fragrance when dried.
Habitat
Red clover thrives in a wide range of temperate habitats, including meadows, pastures, grasslands, roadsides, field margins, waste ground, and open woodlands. It prefers moderately moist, well-drained soils of moderate to good fertility but tolerates a range of soil types from sandy loams to heavy clays, with a soil pH range of 6.0-7.5 (slightly acidic to neutral). As a legume, it fixes atmospheric nitrogen through its Rhizobium root nodule symbiosis, allowing it to colonize nitrogen-poor soils and improve soil fertility -- a property that has made it one of the most important agricultural cover crops and green manures in temperate farming. It is moderately shade-tolerant but flowers most prolifically in full sun. Red clover is susceptible to powdery mildew, clover rot (Sclerotinia trifoliorum), and various viral diseases, which can limit its persistence in perennial stands.
Distribution
Trifolium pratense is native to Europe, western Asia, and northwestern Africa, where it is a common component of natural meadow and grassland communities. It has been introduced and naturalized worldwide through centuries of agricultural cultivation as a forage crop, cover crop, and green manure. It is now found throughout North America (where it was introduced by early European colonists and is now one of the most widespread naturalized legumes), South America, East Asia, Australia, New Zealand, and southern Africa. In many regions it is so thoroughly naturalized that it is perceived as a native plant. It grows from lowland to montane elevations, typically below 2500 m. Major commercial cultivation for seed and forage occurs in North America, Europe, and parts of South America and Australasia.
Parts Used
Flower heads (capitula, inflorescences)
Preferred: Dried flower heads for infusion; tincture; standardized isoflavone extract
The dried flower heads are the traditional and primary pharmacopeial drug part. They contain the highest concentration of the key isoflavone constituents (biochanin A, formononetin, genistein, daidzein) and are the part specified in the British Herbal Pharmacopoeia, the European Medicines Agency (EMA) monograph, and most traditional herbal references. The flowers also contain the flavonoids, phenolic acids, volatile oil, and other bioactive compounds. Whole, intact flower heads with retained pink-purple color are preferred quality indicators. Heavily browned or fragmented material is considered inferior. AHPA botanical safety handbook rates the flowers as Class 1 (can be safely consumed when used appropriately).
Aerial parts (herb -- flowers, leaves, and upper stems)
Preferred: Dried herb for infusion; tincture; fresh plant juice (Succus)
Some traditional and contemporary preparations use the entire aerial portion of the flowering plant, including the characteristic trifoliate leaves and upper stems. The leaves contain appreciable isoflavone content (approximately 40-60% of flower head concentration) and contribute additional flavonoids, chlorophyll, and mineral content. The British Herbal Pharmacopoeia allows 'flowering tops' which includes upper leaves and stems. Eclectic physicians often used the entire flowering herb. The inclusion of leaves and stems dilutes the isoflavone concentration per gram compared to flower-only preparations.
Sprouted seeds
Preferred: Fresh sprouts consumed as food; freeze-dried sprout powder
Red clover sprouts (germinated seeds consumed as a food) contain significant isoflavone concentrations, particularly genistein and daidzein, which increase substantially during the germination process. Sprouts have been investigated as a dietary source of phytoestrogens and are available commercially as a salad ingredient. They provide a food-form delivery of isoflavones at lower concentrations than standardized supplements but in a whole-food matrix. Sprouts also contain vitamins C, K, and folate, along with dietary fiber.
Key Constituents
Isoflavones (phytoestrogens)
Isoflavones are the primary pharmacologically distinctive constituents of red clover and the basis for its modern clinical use in menopausal symptom management and bone health. These compounds are classified as phytoestrogens -- plant-derived compounds with structural similarity to 17-beta-estradiol that bind estrogen receptors and exert selective estrogen receptor modulator (SERM)-like activity. The preferential binding to ERbeta over ERalpha is considered therapeutically advantageous: ERbeta activation provides estrogenic effects on bone (maintaining density), vasomotor symptoms (reducing hot flashes), and cardiovascular risk factors (improving lipid profiles) while potentially exerting anti-proliferative rather than proliferative effects on breast and uterine tissue. The total isoflavone content of red clover (sum of biochanin A, formononetin, genistein, and daidzein) is substantially higher than that of most other commonly used phytoestrogenic herbs and is the basis for the standardized red clover isoflavone supplements (such as Promensil, standardized to 40 mg total isoflavones per tablet) used in clinical trials. However, it is important to note that isoflavone bioavailability and metabolism vary significantly between individuals due to differences in gut microbiota (particularly equol production capacity), hepatic enzyme polymorphisms, and intestinal absorption.
Coumestans
Coumestrol, while a potent phytoestrogen, is present in only trace amounts in properly harvested red clover flower heads and contributes minimally to the overall phytoestrogenic effect of standard herbal preparations. Its primary relevance is veterinary and agricultural: high coumestrol concentrations in diseased clover pastures have caused significant reproductive problems in livestock. For human herbal medicine, the isoflavones are far more important. Quality control should ensure that red clover material is free of significant fungal infection that could elevate coumestrol to problematic levels.
Flavonoids (non-isoflavone)
Non-isoflavone flavonoids contribute to the overall antioxidant, anti-inflammatory, and mild phytoestrogenic activity of red clover preparations. While individually present at lower concentrations than the principal isoflavones, their collective contribution to the polyphenol matrix may modulate isoflavone bioavailability and provide additive or synergistic antioxidant and anti-inflammatory effects. This supports the whole-herb approach used in traditional herbal medicine, where the totality of constituents may produce effects different from isolated isoflavone supplements.
Phenolic acids
Phenolic acids contribute to the antioxidant capacity and mild anti-inflammatory effects of red clover preparations. The presence of salicylate derivatives provides some pharmacological basis for the traditional use of red clover as a gentle anti-inflammatory and antirheumatic herb, though the salicylate content alone is insufficient to account for significant anti-inflammatory effects. The phenolic acid content supports the overall polyphenol-rich, antioxidant profile of the herb.
Coumarins
The coumarin content of properly prepared red clover products is low and not clinically significant for anticoagulant effects. The persistent concern about red clover and anticoagulation reflects a confusion between: (1) the trace coumarin in Trifolium pratense and (2) the dicoumarol (a potent anticoagulant) produced by mold contamination of Melilotus (sweet clover) hay. Standard red clover herbal preparations do NOT contain dicoumarol and do not produce clinically meaningful anticoagulant effects. However, the theoretical interaction with anticoagulant medications is listed as a precautionary measure in safety assessments, and patients on warfarin or other anticoagulants should inform their healthcare provider about red clover use.
Cyanogenic glycosides
Cyanogenic glycosides are not therapeutically relevant in red clover preparations and are present only at trace levels. They are mentioned for completeness in phytochemical profiling and to address occasional safety queries. Standard drying and extraction processes eliminate any theoretical cyanide risk.
Volatile oil and aromatic compounds
The volatile oil of red clover is not a primary therapeutic constituent but contributes to the organoleptic quality (pleasant taste and aroma) that makes red clover one of the most palatable medicinal infusions. Methyl salicylate content, while very low, adds to the overall anti-inflammatory and analgesic profile.
Minerals and nutrients
The mineral and vitamin content of red clover, while not the primary basis for therapeutic use, contributes to its traditional reputation as a nutritive, 'blood-building' tonic herb. The calcium and mineral content may modestly complement the isoflavone-mediated bone-protective effects. Long infusion (4-8 hours) is the preparation method that best extracts the mineral content. Red clover sprouts provide the highest vitamin content.
Herbal Actions
Gradually restores proper body function and increases overall health
Red clover is one of the most important alterative ('blood-cleansing') herbs in the Western herbal tradition, with a documented history of alterative use spanning at least 500 years in European herbalism and extensively in 19th-century American Eclectic medicine. The alterative action refers to the herb's ability to gradually improve tissue nutrition, enhance elimination of metabolic waste products through the lymphatic system, kidneys, and skin, and support the resolution of chronic inflammatory and eruptive conditions (particularly skin diseases, swollen lymph nodes, and glandular congestion). The mechanism of alterative action is multifactorial and not fully elucidated in reductionist pharmacological terms, but likely involves: (1) isoflavone-mediated modulation of estrogen metabolism and detoxification pathways, (2) support of hepatic biotransformation and elimination, (3) lymphatic system stimulation and drainage, (4) anti-inflammatory effects on chronic tissue inflammation, and (5) improved capillary integrity and peripheral circulation. The Eclectic physicians John King, Harvey Wickes Felter, and John Uri Lloyd all considered red clover a first-line alterative, particularly for skin eruptions, scrofulous conditions, and chronic cough.
[1, 2, 3]Red clover demonstrates a specific tropism for the lymphatic system, enhancing lymphatic circulation, reducing lymphatic congestion, and supporting the resolution of swollen or hardened lymph nodes. This lymphatic activity is central to its traditional alterative reputation and its extensive use for conditions involving glandular swelling (lymphadenopathy), breast cysts and lumps, and lymphatic congestion. The Eclectic physicians specifically noted red clover's affinity for lymphatic conditions, including 'scrofulous' presentations (chronic lymphatic enlargement). Modern herbalists including David Hoffmann, Kerry Bone, and Simon Mills continue to regard red clover as one of the premier lymphatic herbs in the Western materia medica. The lymphatic action complements and overlaps with its alterative, anti-inflammatory, and phytoestrogenic properties.
[2, 3, 4]Red clover contains the highest isoflavone concentration of any commonly used Western medicinal herb. The four principal isoflavones (biochanin A, formononetin, genistein, daidzein) act as selective estrogen receptor modulators (SERMs), binding preferentially to estrogen receptor beta (ERbeta) with approximately 10-30 fold selectivity over ERalpha. This SERM-like activity provides tissue-selective estrogenic effects: estrogenic activity on bone (supporting osteoblast function and bone density), vasomotor regulation (reducing hot flash frequency and severity), cardiovascular system (improving lipid profiles and arterial compliance), and vaginal tissue (reducing atrophic changes), while potentially exerting anti-proliferative effects on breast tissue through ERbeta-mediated mechanisms. Multiple randomized controlled trials using standardized red clover isoflavone extracts (particularly Promensil, 40-80 mg total isoflavones daily) have demonstrated clinically significant reductions in hot flash frequency and improvements in menopausal symptom scores compared to placebo. The phytoestrogenic potency of red clover isoflavones is approximately 100-1000 fold weaker than endogenous 17-beta-estradiol, placing them in the category of weak estrogen receptor agonists.
[6, 7, 8, 9]Relieves smooth muscle spasm
Red clover demonstrates mild smooth muscle relaxant and antispasmodic activity, traditionally applied to cough suppression, bronchospasm, and menstrual cramps. The antispasmodic mechanism is not fully characterized but may involve isoflavone-mediated modulation of smooth muscle calcium channels and phytoestrogenic effects on uterine smooth muscle tone. The Eclectic physicians noted red clover's ability to calm 'spasmodic' coughs, particularly in children, and it was included in numerous cough formulae. The antispasmodic activity is gentle and supportive rather than potent, making red clover suitable for chronic or constitutional use rather than acute spasm relief.
[2, 3]Promotes the discharge of mucus from the respiratory tract
Traditional expectorant use is well established in Western herbalism, where red clover flower infusion has been used for productive cough, bronchitis, and upper respiratory catarrh. The mechanism likely involves a combination of mild saponin-like action on bronchial mucosa (stimulating mucociliary clearance), anti-inflammatory effects reducing bronchial mucosal swelling, and antispasmodic activity relaxing bronchial smooth muscle. Red clover was specifically included in many traditional cough syrups and pectoral teas in both European and American herbal traditions. The expectorant action is gentle and well-suited for chronic, dry, or irritable coughs rather than acute productive coughs with copious expectoration.
[1, 2, 3]Reduces inflammation
Multiple mechanisms contribute to the anti-inflammatory action of red clover: isoflavones (particularly genistein and biochanin A) inhibit NF-kB signaling, suppress COX-2 expression, and reduce pro-inflammatory cytokine production (TNF-alpha, IL-1beta, IL-6); flavonoids and phenolic acids provide antioxidant protection against inflammatory free radical generation; and trace salicylate derivatives contribute mild anti-inflammatory effects. In vitro studies demonstrate that red clover isoflavone extracts inhibit TNF-alpha-induced vascular inflammation and reduce expression of adhesion molecules (VCAM-1, ICAM-1) on endothelial cells. The anti-inflammatory action supports its use in chronic skin conditions (eczema, psoriasis), joint inflammation, and chronic respiratory inflammation.
[1, 10]Red clover has a specific traditional reputation for improving chronic skin conditions, particularly eczema, psoriasis, and skin eruptions of various kinds. This dermatological action is considered a specific expression of its broader alterative and lymphatic activities. The traditional understanding is that red clover improves skin health by enhancing the body's elimination of metabolic waste products through improved lymphatic drainage, hepatic detoxification, and kidney function, thereby reducing the 'toxic burden' that contributes to skin eruptions. The isoflavone content may additionally contribute through anti-inflammatory effects on dermal tissue and modulation of keratinocyte proliferation. Topical application of red clover preparations (poultices, washes) has also been used traditionally for skin conditions, burns, and ulcers.
[2, 3, 4]Red clover is classified as a nutritive tonic herb in Western herbalism, providing minerals (calcium, magnesium, potassium, chromium, iron), vitamins, and phytonutrients in a bioavailable, food-like matrix. This nutritive quality is best accessed through long infusion (4-8 hours of steeping), which maximizes mineral extraction. Herbalist Susun Weed has been particularly influential in promoting red clover long infusion as a daily nutritive beverage for women's health, bone health, and general vitality. The nutritive action complements and supports the phytoestrogenic and alterative actions.
[2, 5]Red clover produces a mild diuretic effect, increasing urine output and supporting renal elimination of metabolic waste products. This action contributes to its alterative reputation and its traditional use in conditions associated with fluid retention and metabolic congestion. The diuretic mechanism is likely related to the flavonoid and mineral salt content rather than to the isoflavones. The effect is gentle and non-depleting of potassium (in contrast to pharmaceutical loop or thiazide diuretics), as red clover itself provides significant potassium content.
[1, 2]Therapeutic Indications
Reproductive System
Menopausal symptoms (hot flashes, night sweats, vasomotor symptoms)
The most extensively studied clinical indication for red clover isoflavone extracts. Multiple randomized controlled trials have evaluated standardized red clover isoflavone preparations (particularly Promensil, containing 40-80 mg total isoflavones per day) for menopausal symptom relief. Atkinson et al. (2004) found that red clover isoflavone supplementation (40 mg/day) significantly improved menopausal symptoms including hot flash frequency and severity in postmenopausal women over 12 months. Tice et al. (2003) conducted a well-designed RCT evaluating Promensil (82 mg isoflavones) and Rimostil (57 mg isoflavones) versus placebo in 252 menopausal women, finding significant reductions in hot flash frequency with Promensil by month 12 (though not at the primary endpoint of month 3, suggesting a delayed onset of action). Nelson et al. (2006) conducted a meta-analysis and systematic review of isoflavone supplements for menopausal hot flashes, concluding that red clover isoflavone extracts produced modest but statistically significant reductions in hot flash frequency compared to placebo. The magnitude of effect (approximately 30-50% reduction in hot flash frequency beyond placebo) is clinically meaningful though less robust than hormone replacement therapy. Response may be influenced by individual equol-producer phenotype.
[6, 7, 9, 10]Postmenopausal bone density maintenance
Booth et al. (2006) conducted a randomized, double-blind, placebo-controlled trial of red clover isoflavones (Promensil, 40 mg/day) combined with a walking program in postmenopausal women over 12 months. The combination of isoflavones plus exercise significantly attenuated the rate of lumbar spine bone mineral density loss compared to placebo plus exercise. The isoflavone-only group (without exercise) also showed a trend toward bone preservation. The mechanism involves isoflavone-mediated stimulation of osteoblast activity and inhibition of osteoclast-driven bone resorption, likely through ERbeta-mediated signaling in bone cells. Formononetin and its metabolite daidzein have demonstrated promotion of osteoblast differentiation in vitro. Atkinson et al. (2004) also reported improvements in bone health markers with red clover isoflavone supplementation. While the evidence supports a bone-protective effect, red clover isoflavones should not replace standard osteoporosis prevention and treatment measures but may serve as a complementary approach.
[6, 8]Menopausal mood changes and quality of life
Several clinical trials have reported improvements in menopausal quality of life scores, including mood, anxiety, and general well-being, with red clover isoflavone supplementation. Atkinson et al. (2004) found improvements in the Greene Climacteric Scale domains including psychological and somatic symptoms. The mechanism may involve ERbeta-mediated effects on serotonin and other neurotransmitter systems, as well as the indirect mood benefit of reduced vasomotor symptoms and improved sleep. Evidence is preliminary, as mood improvement was typically a secondary outcome rather than the primary endpoint of studies.
[6, 10]Premenstrual syndrome (PMS) and cyclic mastalgia
Traditional use of red clover for premenstrual symptoms, particularly breast tenderness (cyclic mastalgia) and hormonal fluid retention. The phytoestrogenic SERM-like activity may modulate hormonal fluctuations contributing to PMS symptoms. The lymphatic action may help reduce breast congestion and tenderness. Limited formal clinical trial evidence specifically for PMS; use is primarily based on traditional practice and extrapolation from the phytoestrogenic mechanism.
[2, 4]Postmenopausal vaginal atrophy and dryness
Estrogen receptor-mediated effects on vaginal epithelium may help maintain tissue integrity and reduce atrophic changes associated with declining estrogen levels. Some clinical studies have reported improvements in vaginal health parameters (cytological maturation index, vaginal pH, subjective dryness and discomfort) with isoflavone supplementation. Topical application of isoflavone-containing preparations has also been investigated. Evidence is preliminary and less robust than for hot flash reduction.
[6, 10]dermatological
Eczema (atopic dermatitis)
Red clover has a long traditional history as an alterative herb for chronic eczema. The approach is constitutional rather than symptomatic: red clover is used over weeks to months to gradually improve the body's eliminative function, reduce systemic inflammation, and improve tissue nutrition, with the expectation that skin health improves as the overall 'toxic burden' decreases. The anti-inflammatory isoflavones may contribute directly to reduced dermal inflammation. Both internal use (infusion, tincture) and external use (poultice, wash, bath) are traditional. The Eclectic physicians used red clover extensively for eczematous conditions, particularly in children. Modern clinical trial evidence specifically for eczema is limited; use is based on strong traditional evidence and pharmacological plausibility.
[2, 3, 4]Psoriasis
Red clover is traditionally used as part of an alterative approach to psoriasis management. The rationale includes its lymphatic-stimulating, anti-inflammatory, and hepatic-supportive properties that address the constitutional factors thought to contribute to psoriatic disease in the naturopathic and herbal medicine model. Genistein has demonstrated inhibition of keratinocyte proliferation in vitro, which is theoretically relevant to psoriasis (a disease of excessive keratinocyte turnover). Clinical evidence is limited to traditional use reports and case series; no controlled clinical trials specifically for psoriasis have been published.
[2, 3]Chronic skin eruptions and acne
The traditional alterative indication encompasses various chronic skin eruptions, including acne, boils, carbuncles, and skin ulcers. Red clover was a key ingredient in many traditional 'blood-purifying' formulae for skin conditions. The Eclectic physicians specifically recommended it for 'scrofulous' skin eruptions and glandular swelling associated with poor skin health. Internal use is combined with good diet and other eliminative support.
[2, 3]Lymphatic System
Lymphatic congestion and swollen lymph nodes
Red clover is a premier lymphatic herb in Western herbalism, traditionally indicated for chronic lymphatic congestion manifesting as swollen, hard, or tender lymph nodes, particularly in the cervical (neck), axillary (armpit), and inguinal (groin) regions. The Eclectic physicians used red clover extensively for 'scrofula' -- a historical term for chronic lymphatic enlargement, often tuberculous in origin but applied more broadly to lymphatic congestion of any cause. The lymphatic action involves stimulation of lymphatic circulation and drainage, enhanced macrophage and lymphocyte activity within lymph nodes, and reduction of lymphatic stasis. Modern herbalists continue to prescribe red clover as a key component of lymphatic formulae, often combined with Galium aparine (cleavers), Calendula officinalis (calendula), and Phytolacca decandra (poke root). Clinical trial evidence specifically for lymphatic congestion is absent; use is based on extensive traditional evidence.
[2, 3, 4]Fibrocystic breast changes and breast cysts
Traditional use for benign breast lumps, cysts, and fibrocystic breast changes is well established in Western herbalism. The combined lymphatic, alterative, and phytoestrogenic actions make red clover particularly well-suited for breast tissue conditions. The lymphatic action supports drainage of congested breast tissue, while the phytoestrogenic SERM-like activity may help modulate the hormonal factors contributing to fibrocystic changes. Herbalists David Hoffmann and Kerry Bone both include red clover in protocols for benign breast conditions. No controlled clinical trials specifically for fibrocystic breast changes. Note: any persistent or new breast lump requires medical evaluation to exclude malignancy.
[2, 4]Respiratory System
Cough and bronchitis (chronic, dry, or spasmodic)
Red clover flower infusion has a long traditional history as a gentle cough remedy, particularly for chronic dry cough, spasmodic cough (including whooping cough historically), and bronchial irritation. The Eclectic physicians valued it as a safe expectorant suitable for children and the elderly. The mechanism involves mild antispasmodic relaxation of bronchial smooth muscle, gentle stimulation of mucociliary clearance, and anti-inflammatory effects on bronchial mucosa. Red clover tea sweetened with honey is one of the most time-honored domestic cough remedies in British and American herbal traditions. It is typically used for chronic or constitutional respiratory conditions rather than acute infections.
[1, 2, 3]Upper respiratory catarrh
Traditional use for chronic upper respiratory catarrh (excess mucus production in the nose, sinuses, and throat). The gentle expectorant and anti-inflammatory actions help reduce mucus production and clear congestion. Often combined with other anticatarrhal herbs such as elderflower (Sambucus nigra), ground ivy (Glechoma hederacea), and eyebright (Euphrasia spp.).
[2, 3]Cardiovascular System
Cardiovascular risk factor modification (lipid profiles, arterial compliance)
Several clinical studies have investigated the effects of red clover isoflavone supplements on cardiovascular risk factors. Improvements in lipid profiles (reductions in LDL cholesterol, increases in HDL cholesterol) and improvements in arterial compliance (a measure of arterial stiffness) have been reported in postmenopausal women taking standardized isoflavone extracts. Nestel et al. (2004) found significant improvement in systemic arterial compliance with red clover isoflavones (80 mg/day) in postmenopausal women. The mechanism involves isoflavone-mediated enhancement of endothelial nitric oxide production, anti-inflammatory effects on vascular endothelium, and modulation of lipid metabolism. The cardiovascular indication is secondary to the primary menopausal and bone health indications but provides supporting evidence for the cardiovascular-protective aspect of isoflavone therapy.
[6, 10]oncology
Traditional 'anti-cancer' herb (Hoxsey formula component)
IMPORTANT CONTEXT: Red clover has a long historical association with cancer treatment in folk medicine, most notably as a key ingredient in the Hoxsey formula -- a controversial herbal cancer treatment promoted by Harry Hoxsey from the 1920s through the 1950s. The Hoxsey formula (which also included Berberis root, Stillingia root, Cascara sagrada, Phytolacca root, Potassium iodide, and other ingredients) was condemned by the FDA and mainstream oncology as an unproven cancer remedy. Red clover was also used independently in folk medicine as a 'blood purifier' for tumors and 'growths.' The isoflavone genistein has demonstrated anti-proliferative, pro-apoptotic, anti-angiogenic, and anti-metastatic activity in numerous in vitro and animal studies. However, these preclinical findings have NOT been translated into evidence supporting the use of red clover as a cancer treatment in humans. There are NO randomized controlled trials demonstrating that red clover or its isoflavones are effective cancer treatments. The historical use is documented here for completeness and historical accuracy, NOT as a clinical recommendation. Red clover should NOT be promoted as a cancer treatment or cancer preventive agent. Patients with cancer should rely on evidence-based oncological treatments.
[1, 3]Energetics
Temperature
cool
Moisture
slightly moist
Taste
Tissue States
hot/excitation, dry/atrophy, damp/stagnation
In Western herbal energetics, red clover is classified as cool and slightly moist -- a gentle, nourishing herb that clears heat and moistens dryness without creating excessive dampness. The sweet taste reflects its nutritive, tonic quality and its gentle, food-like nature (red clover tea is one of the most pleasant-tasting medicinal infusions). The slightly salty taste corresponds to its mineral content and mild diuretic action. Red clover addresses hot/excitation tissue states (chronic inflammation, hot skin eruptions, inflammatory lymphatic congestion, menopausal heat/hot flashes), dry/atrophic states (postmenopausal vaginal and tissue dryness, dry skin, bone loss), and damp/stagnant states (lymphatic congestion, metabolic sluggishness, glandular swelling). Its cool, moistening energetics make it particularly well-suited for perimenopausal and postmenopausal women experiencing heat signs (hot flashes, night sweats) with concurrent dryness. It is less appropriate for cold, damp constitutional types with loose stools and poor digestion, where its cooling, moistening nature may exacerbate symptoms. The gentle, food-grade nature of red clover means it is broadly tolerated across most constitutional types when used as a nutritive infusion rather than a concentrated extract. CAVEAT: Herbal energetics are interpretive frameworks within Western herbalism, not standardized across all practitioners.
Traditional Uses
European folk medicine (medieval to early modern period)
- Infusion of flower heads as a 'blood purifier' and spring tonic for cleansing the body after winter
- Poultice of fresh flowers applied to skin eruptions, sores, burns, and ulcers
- Cough remedy: flower infusion sweetened with honey for persistent cough and bronchial complaints
- External wash for irritated, inflamed skin and wound healing
- Domestic remedy for childhood coughs and whooping cough
- Flowers steeped in vinegar as a topical application for skin conditions
"Red clover has been used in European folk medicine since at least the medieval period, though written documentation is sparse before the herbals of the 16th and 17th centuries. Gerard's Herball (1597) mentions clover primarily in agricultural terms but notes its use as a poultice for skin conditions. Culpeper (1653) describes clover as cooling and useful for inflamed surfaces. The widespread use of red clover infusion as a domestic cough remedy and blood purifier was transmitted through oral folk tradition across Britain, Ireland, and continental Europe for centuries before formal documentation in pharmacopeias."
American Eclectic medicine (19th-early 20th century)
- First-line alterative for chronic skin diseases: eczema, psoriasis, skin eruptions, scrofula
- Lymphatic remedy for chronic glandular swelling and lymphatic congestion
- Antispasmodic for whooping cough (pertussis) in children
- Expectorant for chronic bronchial conditions
- Component of cancer-treating formulae (Hoxsey-type combinations)
- Mild sedative and nervine for restlessness and irritability associated with chronic disease
- External application (fomentation, poultice) for indolent ulcers and skin cancers
"The Eclectic physicians of the 19th and early 20th centuries used red clover extensively and regarded it as one of the foremost alterative herbs in their materia medica. Felter and Lloyd's King's American Dispensatory (1898) provides a detailed monograph: 'Red clover has enjoyed a long reputation as an alterative. Its uses are chiefly in chronic skin diseases, particularly eczema, and in pertussis. The infusion is a pleasant, mildly stimulating beverage.' Harvey Wickes Felter's The Eclectic Materia Medica, Pharmacology and Therapeutics (1922) states: 'Trifolium is an old remedy for cancerous growths, scrofula, and chronic skin disorders of a rebellious character. It has given good results in stubborn cases of eczema, particularly in children, and in the dry, scaly forms of skin disease. A saturated tincture of the fresh blossoms is most effective.' The Eclectics also noted its value as a respiratory antispasmodic, particularly for whooping cough, and its gentle action made it one of the few alteratives considered safe for children."
Native American traditional medicine
- Infusion of flower heads for coughs, colds, and respiratory complaints
- Poultice for skin irritations, sores, and burns
- Infusion as a gentle sedative and calming agent
- General tonic and nutritive beverage
- Eye wash for sore or inflamed eyes (dilute infusion)
- Used by multiple tribes including Cherokee, Iroquois, and Algonquin peoples
"While red clover was introduced to North America by European colonists (it is not native to the Americas), several Native American tribes adopted its use relatively quickly after its naturalization. The Cherokee used red clover infusion as an expectorant and for liver support. The Iroquois used it for coughs, fevers, and as a blood purifier. Daniel Moerman's Native American Ethnobotany documents use by multiple tribes for respiratory, dermatological, and general tonic purposes. However, these uses postdate European contact and should not be characterized as ancient or pre-Columbian traditions."
Hoxsey formula and alternative cancer movement (20th century)
- Key ingredient in the Hoxsey herbal tonic for cancer treatment
- Used in combination with Berberis root, Stillingia root, Cascara sagrada, Phytolacca root, Potassium iodide, Burdock root, and Licorice root
- Promoted as an internal treatment for various cancers from the 1920s-1950s
- External paste (escharotic) containing red clover applied to skin cancers
"Harry Hoxsey promoted an herbal cancer treatment from the 1920s through the 1950s that featured red clover as a primary ingredient. The formula was claimed to have been passed down from his great-grandfather, who allegedly observed a horse with cancer recover after grazing on certain plants including red clover. The Hoxsey formula was the most commercially successful alternative cancer treatment of its era, with clinics treating tens of thousands of patients. The FDA and National Cancer Institute condemned the treatment as unproven, and Hoxsey's US clinics were closed by FDA injunction in the 1960s. A clinic continued to operate in Tijuana, Mexico. While the Hoxsey treatment has not been validated by controlled clinical trials and is NOT recommended as a cancer treatment, it represents an important chapter in the history of botanical medicine and alternative cancer therapy, and red clover's inclusion in this formula has significantly shaped its popular reputation as a 'cancer herb.' DISCLAIMER: This historical documentation does not constitute endorsement of the Hoxsey formula or any herbal cancer treatment as a substitute for evidence-based oncological care."
[1]
British herbalism (contemporary Western herbal medicine)
- Alterative for chronic skin conditions (eczema, psoriasis, acne)
- Lymphatic herb for swollen glands, lymphatic congestion, and breast cysts
- Menopausal support (hot flashes, night sweats, bone health)
- Nutritive tonic (long infusion) for mineral supplementation
- Component of alterative and lymphatic herbal formulae
- Gentle children's remedy for coughs and skin conditions
"British herbalism has maintained a continuous tradition of red clover use from folk medicine through to contemporary professional practice. The British Herbal Pharmacopoeia (BHP 1983) includes a monograph for Trifolium pratense flower heads, listing actions as antispasmodic, expectorant, and alterative, with indications including skin diseases, bronchitis (especially whooping cough), and as a background alterative remedy. David Hoffmann's Medical Herbalism (2003) describes red clover as 'one of the most useful remedies for children with skin problems' and emphasizes its lymphatic and alterative properties. The herb is widely used in clinical practice by UK-trained medical herbalists and is considered one of the safer and more versatile alterative herbs in the materia medica."
Susun Weed and the Wise Woman tradition
- Daily long infusion (4-8 hour steep) as a nutritive mineral tonic for women's health
- Menopausal support through food-grade isoflavone intake
- Bone health and osteoporosis prevention through mineral-rich infusion
- Fertility support and hormonal balance
- General nourishment and vitality
"Herbalist Susun Weed has been particularly influential in promoting red clover as a daily nutritive tonic, especially for women. In her books New Menopausal Years the Wise Woman Way (2002) and Healing Wise (1989), Weed advocates for a 'nourishing herbal infusion' of red clover prepared by steeping a full ounce (approximately 30 g) of dried flower heads in a quart (approximately 1 L) of boiling water for a minimum of 4 hours (preferably 8 hours or overnight). This extended infusion extracts substantially more minerals and nutrients than a standard 10-15 minute infusion. Weed considers red clover infusion one of the supreme daily tonics for women, supporting bone health, hormonal balance, cardiovascular health, and overall vitality through its nutritive and phytoestrogenic properties. This approach emphasizes red clover as a nourishing food-grade herb rather than a pharmaceutical intervention."
[5]
Modern Research
Red clover isoflavones for menopausal symptoms (comprehensive study)
Randomized, placebo-controlled, double-blind trial evaluating the effects of red clover-derived isoflavones (43 mg/day providing biochanin A, formononetin, genistein, and daidzein) on menopausal symptoms, lipid profiles, and bone markers in postmenopausal women over 12 months.
Findings: Red clover isoflavone supplementation significantly improved menopausal symptoms as measured by the Greene Climacteric Scale, with reductions in hot flash frequency and severity compared to placebo. Beneficial effects on bone metabolism markers were observed, including maintenance of bone mineral content in the lumbar spine. Modest improvements in the HDL:LDL cholesterol ratio were also noted. The 12-month study duration was longer than most comparable trials and captured the delayed onset of isoflavone effects. No significant adverse effects were observed, and there were no changes in endometrial thickness or breast density on imaging.
Limitations: Single-center study in a UK population. Moderate sample size. The isoflavone dose (43 mg/day) was at the lower end of the range used in other trials. Individual variation in isoflavone metabolism (equol producer status) was not assessed. The placebo response in menopausal symptom trials is characteristically high (approximately 25-30%), which complicates interpretation of treatment effects.
[6]
Promensil and Rimostil for menopausal hot flashes (large multi-center RCT)
Randomized, double-blind, placebo-controlled trial evaluating two commercially available red clover isoflavone supplements (Promensil 82 mg and Rimostil 57 mg total isoflavones daily) versus placebo in 252 menopausal women experiencing at least 35 hot flashes per week. The primary endpoint was change in mean daily hot flash count at 12 weeks.
Findings: At the primary endpoint of 12 weeks, neither Promensil nor Rimostil showed a statistically significant reduction in hot flash frequency compared to placebo. However, at the secondary endpoint of 12 months, Promensil showed a significant reduction in hot flash frequency compared to placebo, suggesting a delayed onset of action. The placebo response was substantial (approximately 35% reduction in hot flash frequency), consistent with other menopausal symptom trials. The study was important in demonstrating that the time course of isoflavone effects may be longer than the 12-week primary endpoints used in many trials. Both supplements were well tolerated with no significant safety concerns.
Limitations: The negative primary endpoint (12 weeks) was widely cited, while the positive secondary endpoint (12 months) received less attention, creating a somewhat misleading impression in meta-analyses that only considered the primary endpoint. The large placebo response made it difficult to detect treatment effects. The study population may have included a significant proportion of non-equol producers, potentially diluting the treatment effect. The two different supplements contained different isoflavone profiles, complicating comparison.
[7]
Red clover isoflavones and bone mineral density in postmenopausal women
Randomized, double-blind, placebo-controlled trial evaluating the effects of red clover isoflavones (Promensil 40 mg/day) combined with a structured walking exercise program on bone mineral density (BMD), bone metabolism markers, and body composition in postmenopausal women over 12 months.
Findings: The combination of red clover isoflavones plus exercise significantly attenuated the rate of lumbar spine BMD loss compared to placebo plus exercise (P < 0.05). The isoflavone group lost approximately 1.1% less lumbar spine BMD over 12 months compared to the placebo group. Bone turnover markers (serum osteocalcin and urinary deoxypyridinoline) also showed favorable trends in the isoflavone group. The study demonstrated that red clover isoflavones can complement the bone-protective effects of weight-bearing exercise in postmenopausal women. The effect size, while modest, is clinically meaningful given the cumulative nature of bone loss over the postmenopausal decades.
Limitations: Moderate sample size. The exercise component (walking program) was included in both treatment and placebo groups, making it impossible to determine the independent effect of isoflavones on BMD in the absence of exercise. Lumbar spine BMD was the primary outcome; hip BMD changes were not statistically significant. The 40 mg/day dose was at the lower end of the range; higher doses might produce greater effects. Single-center Australian study.
[8]
Isoflavone supplements for menopausal hot flashes (systematic review and meta-analysis)
Comprehensive systematic review and meta-analysis of published randomized controlled trials evaluating the efficacy of isoflavone-containing supplements (from soy and red clover sources) for reducing the frequency and severity of menopausal hot flashes.
Findings: The meta-analysis found that isoflavone supplements produced a statistically significant reduction in hot flash frequency compared to placebo, with a pooled effect size of approximately 30-50% reduction beyond placebo. Red clover isoflavone supplements were associated with modest reductions in hot flash frequency that reached statistical significance in some but not all individual trials. The review noted that study heterogeneity was high, likely due to differences in isoflavone source (soy vs red clover), dose, isoflavone profile (relative proportions of individual isoflavones), study duration, and population characteristics (severity of symptoms at baseline, equol producer status). The authors concluded that isoflavone supplements offer a modest but real benefit for menopausal hot flashes, with the most consistent effects seen in women with more frequent baseline hot flashes and with longer treatment durations.
Limitations: High heterogeneity among included studies complicated pooled analysis. Many included studies had relatively small sample sizes. Few studies assessed equol producer status as a stratification variable. Publication bias was a concern. The placebo response in menopausal symptom trials is characteristically large, making treatment effects harder to detect. Red clover and soy isoflavone results were often pooled, making it difficult to determine the specific efficacy of red clover isoflavones alone.
[9]
Red clover isoflavones: mechanisms, efficacy, and safety review
Comprehensive review article synthesizing the evidence on red clover isoflavone pharmacology, clinical efficacy for menopausal symptoms, bone health, cardiovascular risk factors, and safety in estrogen-sensitive populations.
Findings: The review confirmed that red clover is the richest known source of the methylated isoflavones biochanin A and formononetin, which are converted in vivo to genistein and daidzein respectively. The ERbeta-selective binding profile of these isoflavones provides a mechanistic basis for tissue-selective estrogenic effects. Clinical evidence supports modest efficacy for hot flash reduction, bone density maintenance, and cardiovascular risk factor improvement. Safety data from clinical trials (up to 3 years of exposure) showed no significant adverse effects on endometrial thickness, breast density, or thyroid function. The review noted that individual variation in isoflavone metabolism (particularly equol production capacity) is a major source of variability in clinical outcomes.
Limitations: Narrative review without formal systematic methodology. Predominantly positive interpretation; some negative trials received less discussion. The review was published in a phytomedicine journal, which may introduce publication and interpretation bias.
[10]
Safety of red clover isoflavones in women with hormone-sensitive conditions
Review of available evidence regarding the safety of red clover isoflavone supplements in women with a history of or risk factors for hormone-sensitive cancers, with focus on breast tissue effects.
Findings: Clinical trials of red clover isoflavone supplements (40-160 mg/day for up to 3 years) have consistently found no significant changes in mammographic breast density, endometrial thickness, or serum hormone levels that would indicate increased risk of hormone-sensitive cancers. The ERbeta-selective binding profile of red clover isoflavones theoretically favors anti-proliferative rather than proliferative effects on breast tissue. However, in vitro studies have shown that genistein can stimulate proliferation of ER-positive breast cancer cell lines at low concentrations, creating a biphasic dose-response that introduces uncertainty. The review concluded that while available evidence does not indicate increased cancer risk, the theoretical concerns warrant caution in women with existing hormone-sensitive cancers, and the use of red clover isoflavone supplements in breast cancer survivors should be discussed with their oncologist.
Limitations: No long-term (> 5 year) safety data available. Most studies measured surrogate safety endpoints (breast density, endometrial thickness) rather than cancer incidence. Studies were not specifically designed or powered to detect differences in cancer risk. The in vitro biphasic dose-response of genistein on breast cancer cells remains an unresolved concern.
Equol production and its influence on isoflavone therapy outcomes
Emerging body of research investigating the role of the gut microbiome metabolite equol (produced from daidzein by specific intestinal bacteria) as a determinant of clinical response to isoflavone supplementation.
Findings: Approximately 30-50% of Western populations (and 50-70% of Asian populations) harbor intestinal bacteria capable of converting daidzein to S-equol. Equol is a more potent phytoestrogen than its precursor daidzein, with stronger ERbeta binding affinity and greater antioxidant activity. Equol producers tend to experience significantly greater clinical benefits from isoflavone supplementation, including larger reductions in hot flash frequency, greater bone density preservation, and more favorable cardiovascular risk factor improvements. This 'equol producer' phenotype may explain much of the variability in clinical trial outcomes with red clover and soy isoflavone supplements. The formononetin in red clover is converted to daidzein, which is the direct precursor for equol production. Thus, equol producer status is particularly relevant to red clover therapy.
Limitations: Most studies are observational post-hoc analyses of existing trial data stratified by equol producer status. Prospective RCTs specifically designed to test the equol producer hypothesis are limited. Methods for determining equol producer status vary across studies. The gut microbiome is dynamic and equol production capacity may change with diet and other factors.
Cardiovascular effects of red clover isoflavones
Investigation of the effects of red clover isoflavone supplementation on arterial compliance, blood pressure, lipid profiles, and endothelial function in postmenopausal women.
Findings: Red clover isoflavone supplementation (40-80 mg/day) has been associated with improvements in systemic arterial compliance (a measure of arterial stiffness and cardiovascular risk) in several clinical studies. Nestel et al. (2004) found a significant 23% improvement in arterial compliance with Promensil (80 mg isoflavones/day) compared to placebo over 5 weeks. Modest improvements in lipid profiles (reduction in LDL-C, increase in HDL-C) have been reported in some but not all studies. The mechanisms include isoflavone-mediated enhancement of endothelial nitric oxide synthase (eNOS) activity, anti-inflammatory effects on vascular endothelium, and modulation of lipid metabolism.
Limitations: Short-duration studies (5-12 weeks for most cardiovascular endpoint studies). Small to moderate sample sizes. Arterial compliance is a surrogate marker, not a hard cardiovascular endpoint. Long-term cardiovascular outcome data (heart attack, stroke) are not available. Effects on lipid profiles have been inconsistent across studies.
Preparations & Dosage
Infusion (Tea)
Strength: 2-6 g dried flowers per 250 mL boiling water; traditional infusion ratio approximately 1:40 to 1:125
Place 1-3 teaspoons (2-6 g) of dried red clover flower heads in a teapot or infusion vessel. Pour 250 mL (1 cup) of freshly boiled water over the flowers. Cover and steep for 10-15 minutes. Strain and drink. The resulting infusion is a pleasant, mild, slightly sweet, hay-like tea with a gentle pink-amber color. This is the traditional and most common preparation method, suitable for daily use as a gentle alterative, expectorant, and nutritive tonic.
2-6 g dried flower heads per cup, 2-3 cups daily
Two to three times daily for therapeutic use; once daily for tonic/nutritive maintenance
May be used long-term as a daily tonic. For therapeutic indications (skin conditions, lymphatic congestion), use consistently for a minimum of 4-8 weeks to assess response, and continue for 3-6 months for full alterative effect. Reassess periodically.
For children over 4 years: half adult dose (1-3 g per cup, 1-2 cups daily). Red clover is considered one of the safer herbs for pediatric use.
Standard infusion is the most traditional and widely used preparation. The pleasant taste makes it one of the most palatable medicinal herb teas, which supports patient compliance for the extended treatment courses (weeks to months) required for alterative action. Steeping time should be at least 10 minutes to adequately extract isoflavones; shorter steeping produces a weaker preparation. Using a covered vessel during steeping prevents volatile compound loss.
long-infusion
Strength: 28-30 g dried flowers per 1 L boiling water; ratio approximately 1:33 (much stronger than standard infusion); steeped for 4-8+ hours
Place 28-30 g (approximately 1 ounce) of dried red clover flower heads in a 1-quart (approximately 1 L) glass jar or heat-resistant vessel. Pour freshly boiled water to fill the jar. Cap tightly and let steep for a minimum of 4 hours, preferably 8 hours or overnight. Strain, squeezing the plant material to extract maximum liquid. The resulting infusion will be significantly darker, stronger-tasting, and more mineral-rich than a standard infusion. Refrigerate after straining and consume within 48 hours.
Approximately 28-30 g dried flower heads per 1 L of water. Drink the full quart throughout the day in several portions. This provides a substantially higher isoflavone and mineral dose than standard infusion.
Prepare daily or every other day; drink throughout the day
Can be used as a daily tonic long-term. Susun Weed recommends daily long infusion use for women throughout the menopausal transition and beyond.
Not typically used for children in the long infusion method; standard infusion is preferred for pediatric use.
The long infusion method, popularized by herbalist Susun Weed, extracts substantially more minerals (calcium, magnesium, potassium, iron, chromium) and isoflavones than a standard 10-15 minute infusion. The extended steeping time allows thorough extraction of water-soluble constituents, including mineral salts that require prolonged dissolution. This method treats red clover as a food-grade nutritive tonic rather than a pharmaceutical preparation. The resulting liquid is darker, more intensely flavored, and slightly viscous compared to standard tea. It can be consumed hot or cold.
Tincture
Strength: 1:5, 45-50% ethanol (dried plant); 1:2, 75% ethanol (fresh plant). British Herbal Pharmacopoeia specifies 1:10, 45% ethanol.
Use dried red clover flower heads (or fresh flowers if available). For dried material: macerate at a 1:5 ratio in 45-50% ethanol. Place dried flowers in a clean glass jar, cover with menstruum (45-50% alcohol), seal tightly, and macerate for 4-6 weeks in a cool, dark place with daily agitation. For fresh flowers: use a 1:2 ratio in 75% ethanol (higher alcohol content needed to account for water content in fresh plant material). After maceration, press and strain through muslin, then filter through coffee filter for clarity. The finished tincture should have a deep reddish-brown color and a sweet, floral, slightly astringent taste.
2-6 mL (40-120 drops) three times daily. Start at the lower dose and increase based on response. For acute cough: 2-3 mL every 2-3 hours.
Two to three times daily for chronic/alterative use; more frequently (every 2-3 hours) for acute cough
May be used long-term for alterative indications. For acute conditions, use for the duration of symptoms.
For children over 4 years: glycerite preparation preferred over alcohol tincture. If using tincture: 0.5-1 mL per dose diluted in water or juice, 2-3 times daily.
Tincture is a convenient and concentrated form of administration that extracts both water-soluble and alcohol-soluble constituents, including the isoflavones. The 45-50% alcohol concentration provides efficient isoflavone extraction. Tincture allows precise dosing and is easily incorporated into herbal formulae combining red clover with other alterative, lymphatic, or respiratory herbs. However, the isoflavone dose achievable through standard tincture dosing is lower than that provided by standardized extract supplements used in clinical trials.
Standardized Extract
Strength: Standardized to 40 mg total isoflavones per tablet (Promensil). Other products may vary. The standardization is based on total isoflavone content (sum of biochanin A + formononetin + genistein + daidzein) determined by HPLC.
Commercially prepared standardized red clover isoflavone extracts, typically extracted from red clover flowers and leaves, and standardized to a specific total isoflavone content. The most extensively studied product is Promensil (Novogen Ltd.), standardized to 40 mg total isoflavones per tablet (containing biochanin A, formononetin, genistein, and daidzein in proportions reflective of the whole plant). Other commercial products include Rimostil (57 mg isoflavones, different isoflavone profile) and various generic red clover isoflavone supplements.
40-80 mg total isoflavones daily (equivalent to 1-2 tablets of Promensil). Clinical trials have used doses ranging from 40-160 mg total isoflavones per day. The 40 mg dose showed efficacy in several trials; 80 mg showed dose-dependent improvements in some outcomes. Higher doses (> 160 mg/day) have not been extensively studied.
Once to twice daily, taken with meals
Clinical trials have used 12 weeks to 3 years of continuous supplementation. Effects on hot flashes may require 8-12 weeks to become apparent (delayed onset of action). For bone health, longer-term use (12+ months) is recommended.
Not recommended for children or adolescents. Standardized isoflavone extracts are formulated for adult menopausal use.
Standardized extracts are the form used in the majority of published clinical trials and provide the most reproducible and quantified isoflavone dosing. They represent a pharmaceutical approach to red clover therapy, in contrast to the whole-herb traditional preparations (infusion, tincture). The standardized extract approach allows comparison with clinical trial evidence and specific isoflavone dosing. However, standardized extracts may not contain the full spectrum of constituents (flavonoids, phenolic acids, minerals, volatile compounds) present in whole-herb preparations, and some herbalists argue that the whole-herb approach provides a more balanced and synergistic therapeutic effect. Product quality varies among manufacturers; third-party testing for isoflavone content is advisable.
Capsule / Powder
Strength: Crude powder: 500 mg per capsule. Extract powder: varies by manufacturer.
Dried red clover flower heads, finely powdered (ground to pass through a 40-60 mesh sieve), filled into vegetarian or gelatin capsules. Alternatively, freeze-dried flower powder or concentrated extract powder may be encapsulated.
Crude powder: 2-4 g daily (4-8 capsules of 500 mg) in divided doses. Extract powder: varies by concentration; follow manufacturer guidelines.
Two to three times daily with meals
May be used long-term
Not generally available in capsule form for children. Infusion is preferred.
Capsules of powdered dried flowers provide a convenient alternative for patients who prefer not to drink tea or take tincture. However, the isoflavone bioavailability from crude, unextracted powder may be lower than from infusion or standardized extracts, as heat and water are needed to liberate some isoflavones from the plant matrix. Capsules are a compromise between convenience and optimal extraction.
[1]
topical-poultice
Strength: Fresh flowers: applied directly. Fomentation: double-strength infusion (10-12 g per 250 mL)
For fresh poultice: crush or mash fresh red clover flower heads to release juices. Apply the mashed flowers directly to the affected skin area. Cover with a clean cloth or gauze bandage and leave in place for 1-2 hours. For dried flower poultice: reconstitute dried flowers with a small amount of hot water to make a thick paste. Apply warm (not hot) to the skin and cover. For a fomentation: prepare a strong infusion (double strength), soak a clean cloth in the warm infusion, and apply to the affected area.
Apply to affected area 2-3 times daily as needed
Two to three times daily
Continue until skin condition resolves or as directed by practitioner
Suitable for children. Ensure the poultice is not too hot. Monitor for skin irritation.
Topical application of red clover is a traditional method for skin conditions (eczema, psoriasis, ulcers, burns, sores) and for reducing local inflammation and swelling. The isoflavones and other anti-inflammatory constituents can exert direct effects on the skin when applied topically. Some practitioners combine the poultice with a small amount of honey or olive oil to improve skin contact and add the anti-inflammatory and antimicrobial properties of these vehicles. Topical use is typically combined with internal administration for comprehensive alterative treatment of chronic skin conditions.
Syrup
Strength: Concentrated decoction with honey in approximately 2:1 ratio (liquid:honey by volume)
Prepare a double-strength decoction by simmering 50 g of dried red clover flowers in 500 mL of water for 20-30 minutes. Strain thoroughly. Return the liquid to the pot and add 250 g of raw honey (or equal volume of the strained liquid). Warm gently while stirring until the honey is fully dissolved (do not boil). Add 1-2 tablespoons of lemon juice as a preservative. Pour into a clean glass bottle. Store refrigerated for up to 2-3 months.
1-2 tablespoons (15-30 mL) 3-4 times daily for cough
Three to four times daily, or as needed for cough
For the duration of cough symptoms; typically 1-3 weeks
For children over 2 years: 1-2 teaspoons (5-10 mL) 3-4 times daily. Not recommended for children under 1 year (due to honey). For infants under 1 year, use glycerin instead of honey.
Red clover cough syrup is a classic domestic remedy, particularly valued for children's coughs and chronic dry or spasmodic coughs. The combination of red clover's gentle expectorant and antispasmodic actions with honey's demulcent, soothing, and mild antimicrobial properties makes this an effective and pleasant-tasting cough preparation. The syrup form improves compliance, especially with children. Can be combined with other respiratory herbs such as elecampane (Inula helenium), thyme (Thymus vulgaris), or marshmallow root (Althaea officinalis) for enhanced effect.
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Allergic reactions to red clover are rare but possible, particularly in individuals with known legume allergies. Cross-reactivity with other Fabaceae members (soy, peanut, other clovers) is theoretically possible though not commonly documented. Individuals with confirmed allergy to red clover should not use any red clover preparations.
Due to the phytoestrogenic isoflavone content, red clover preparations (particularly concentrated standardized isoflavone extracts) should be used with caution or avoided in women with active estrogen receptor-positive breast cancer, endometrial cancer, or other hormone-sensitive malignancies. While clinical trial data (up to 3 years) have not shown increased breast cancer risk or breast density changes in healthy postmenopausal women, the in vitro observation that genistein can stimulate ER-positive breast cancer cell proliferation at low concentrations raises a theoretical concern that has not been fully resolved. Women with active hormone-sensitive cancers should discuss red clover use with their oncologist. The concern is greatest with concentrated isoflavone extracts and less relevant to traditional whole-flower infusions at standard doses, which provide substantially lower isoflavone doses.
The phytoestrogenic isoflavones in red clover theoretically could stimulate estrogen-dependent tissue growth in conditions such as endometriosis and uterine fibroids. While clinical evidence of worsening these conditions with red clover is lacking, the theoretical concern warrants caution, particularly with concentrated isoflavone supplements at higher doses. Women with active endometriosis or uterine fibroids should consult their healthcare provider before using concentrated red clover isoflavone supplements. Traditional-dose flower infusions are less likely to provide sufficient isoflavone exposure to be problematic.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Warfarin and other vitamin K antagonist anticoagulants (Anticoagulants) | theoretical | Red clover contains trace amounts of coumarin, a compound with weak anticoagulant properties. IMPORTANT DISTINCTION: The coumarin in Trifolium pratense is NOT dicoumarol (the potent anticoagulant produced by mold contamination of Melilotus sweet clover hay that led to warfarin development). The coumarin content of properly prepared red clover products is extremely low and unlikely to produce clinically significant anticoagulant effects. However, a theoretical additive effect with pharmacological anticoagulants is listed as a precautionary interaction in most references. |
| Tamoxifen, raloxifene, and other selective estrogen receptor modulators (SERMs) (Anti-estrogen / SERM therapy) | theoretical | Red clover isoflavones act as phytoestrogens with SERM-like activity, binding estrogen receptors (preferentially ERbeta). Concurrent use with pharmaceutical SERMs (tamoxifen for breast cancer, raloxifene for osteoporosis) could theoretically produce competitive receptor interactions that might either enhance or reduce the activity of the pharmaceutical SERM. In vitro studies suggest that genistein can antagonize the anti-proliferative effects of tamoxifen on ER-positive breast cancer cells under certain conditions. |
| Aromatase inhibitors (anastrozole, letrozole, exemestane) (Anti-estrogen therapy (aromatase inhibition)) | theoretical | Aromatase inhibitors work by blocking the conversion of androgens to estrogens, maximally reducing circulating estrogen levels in postmenopausal breast cancer patients. The introduction of exogenous phytoestrogens from red clover could theoretically counteract the estrogen-lowering intent of aromatase inhibitor therapy by providing an alternative source of estrogen receptor agonism. Some in vitro studies suggest that formononetin may itself inhibit aromatase, but the net effect of this combined with direct ER agonism is uncertain. |
| Oral contraceptives and hormone replacement therapy (HRT/MHT) (Hormonal preparations) | minor | Additive estrogenic effects from combining pharmaceutical estrogen preparations with phytoestrogenic red clover isoflavones. The phytoestrogenic potency of isoflavones is approximately 100-1000 fold weaker than pharmaceutical estrogens, making clinically significant additive effects unlikely at standard doses. |
| Methotrexate and other hepatically metabolized drugs (CYP substrates) (Various (CYP1A2 and CYP3A4 substrates)) | theoretical | In vitro studies suggest that biochanin A and other red clover isoflavones can inhibit cytochrome P450 enzymes, particularly CYP1A2 and CYP3A4, at high concentrations. This could theoretically slow the hepatic metabolism of drugs metabolized by these enzymes, increasing their plasma levels and potentially their toxicity. |
Pregnancy & Lactation
Pregnancy
possibly unsafe
Lactation
insufficient data
Red clover is classified as Class 2b by the AHPA (not to be used during pregnancy). The phytoestrogenic isoflavone content raises theoretical concerns about hormonal effects on fetal development, particularly during critical periods of sexual differentiation. While red clover flower tea has been consumed as a food/beverage by pregnant women historically without documented adverse effects, the concentrated isoflavone exposure from standardized supplements has not been evaluated for safety in pregnancy. As a precautionary measure, therapeutic doses of red clover supplements (particularly standardized isoflavone extracts) should be avoided during pregnancy. Occasional consumption of red clover tea as a beverage (not as a therapeutic agent) is likely low-risk but not formally studied. During lactation, isoflavones are excreted in breast milk and could theoretically provide phytoestrogenic exposure to the nursing infant. The clinical significance of this is unknown. As a precaution, therapeutic doses of concentrated isoflavone supplements should be avoided during breastfeeding until safety data are available. Brief, occasional use of red clover tea in food amounts during lactation is likely low-risk.
Adverse Effects
References
Monograph Sources
- [1] Blumenthal M, Goldberg A, Brinckmann J (editors). Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Integrative Medicine Communications, Newton, MA (2000)
- [2] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press, Rochester, VT (2003)
- [3] Felter HW. The Eclectic Materia Medica, Pharmacology and Therapeutics. John K. Scudder, Cincinnati, OH (1922)
- [4] Bone K, Mills S. Principles and Practice of Phytotherapy: Modern Herbal Medicine (2nd edition). Churchill Livingstone/Elsevier, Edinburgh (2013)
- [5] Weed S. New Menopausal Years the Wise Woman Way: Alternative Approaches for Women 30-90. Ash Tree Publishing, Woodstock, NY (2002)
Clinical Studies
- [6] Atkinson C, Compston JE, Day NE, Dowsett M, Bingham SA. The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr (2004) ; 79 : 326-333 . DOI: 10.1093/ajcn/79.2.326 . PMID: 14749241
- [7] Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA (2003) ; 290 : 207-214 . DOI: 10.1001/jama.290.2.207 . PMID: 12851275
- [8] Booth NL, Piersen CE, Banuvar S, Geller SE, Shulman LP, Farnsworth NR. Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review. Menopause (2006) ; 13 : 251-264 . DOI: 10.1097/01.gme.0000198297.40269.f7 . PMID: 16645539
- [9] Nelson HD, Vesco KK, Haney E, Fu R, Nedrow A, Miller J, Nicolaidis C, Walker M, Humphrey L. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA (2006) ; 295 : 2057-2071 . DOI: 10.1001/jama.295.17.2057 . PMID: 16670414
- [10] Howes JB, Tran D, Brillante D, Howes LG. Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes. Diabetes Obes Metab (2003) ; 5 : 325-332 . DOI: 10.1046/j.1463-1326.2003.00282.x . PMID: 12940870
Traditional Texts
- [11] Felter HW, Lloyd JU. King's American Dispensatory (18th edition, 3rd revision). Ohio Valley Company, Cincinnati, OH (1898)
- [12] British Herbal Medicine Association. British Herbal Pharmacopoeia (BHP 1983): Trifolium pratense. British Herbal Medicine Association, Bournemouth (1983)
Pharmacopeias & Reviews
- [13] European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Trifolium pratense L., flos. EMA/HMPC/270858/2012 (2014)
- [14] Gardner Z, McGuffin M (editors). American Herbal Products Association's Botanical Safety Handbook (2nd edition). CRC Press, Boca Raton, FL (2013)
Last updated: 2026-03-02 | Status: review
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.